Simplified monitoring of aminoglycoside treatment
- PMID: 2097716
Simplified monitoring of aminoglycoside treatment
Abstract
Aminoglycosides are effective but toxic antibiotics. They are usually administered by repeated daily injections with the dosage adjusted according to twice-weakly monitoring of serum concentrations. A recent study involving 60 patients with severe infections proposed simplified administration and monitoring of aminoglycosides. The patients were randomly treated with either gentamicin or netilmicin given by once daily or thrice daily injections. No difference was found in efficacy or in toxicity between the various groups. In drugs excreted by glomerular filtration, the daily dose should be proportional to renal clearance. This we assessed by aminoglycoside clearance, calculated from trough and peak concentrations of the drug in serum. We also estimated creatinine clearance by a simple equation derived from the knowledge that the urinary excretion of creatinine is proportional to the muscle mass, decreasing with age. For women, creatinine clearance (ml/min) should be [150.age (years)].body weight (kg)/serum creatinine (mumol/l). For men less than 70 years, the figure 150 should be substituted by 170, and at 70 years or older, by 160. We used 51Cr-EDTA clearance as an independent arbiter to decide which mode was best suited for monitoring aminoglycoside therapy. The results showed that estimated creatinine clearance corresponded better to 51Cr-EDTA clearance than did aminoglycoside clearance based on assay of serum concentrations (correlation coefficients for patients with single-dose treatment 0.81 vs. 0.72). In the study we monitored aminoglycoside treatment in the conventional manner according to the patient's weight and adjusted the dose after assay of the drug's serum concentration.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
[Serum level-adjusted dosage of once-daily aminoglycoside therapy in critical illness: results of a prospective study].Anasthesiol Intensivmed Notfallmed Schmerzther. 1999 May;34(5):288-95. doi: 10.1055/s-1999-186. Anasthesiol Intensivmed Notfallmed Schmerzther. 1999. PMID: 10372218 Clinical Trial. German.
-
Experience with a once-daily dosing program of aminoglycosides in critically ill patients.Intensive Care Med. 2002 Jul;28(7):936-42. doi: 10.1007/s00134-002-1313-7. Epub 2002 May 30. Intensive Care Med. 2002. PMID: 12122533
-
Serum cystatin C level for better assessment of glomerular filtration rate in cystic fibrosis patients treated by amikacin.J Clin Pharm Ther. 2008 Aug;33(4):409-17. doi: 10.1111/j.1365-2710.2008.00932.x. J Clin Pharm Ther. 2008. PMID: 18613859 Clinical Trial.
-
Efficacy and safety of aminoglycosides once-a-day: experimental and clinical data.Scand J Infect Dis Suppl. 1990;74:249-57. Scand J Infect Dis Suppl. 1990. PMID: 2097713 Review.
-
Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.Drugs Aging. 1997 Apr;10(4):259-77. doi: 10.2165/00002512-199710040-00003. Drugs Aging. 1997. PMID: 9108987 Review.
Cited by
-
Prediction of creatinine clearance by several methods in patients with severe infections.Eur J Clin Pharmacol. 1992;42(2):193-5. doi: 10.1007/BF00278483. Eur J Clin Pharmacol. 1992. PMID: 1618252
-
Population pharmacokinetics of netilmicin in short-term prophylactic treatment.Br J Clin Pharmacol. 2003 Jun;55(6):552-9. doi: 10.1046/j.1365-2125.2003.01783.x. Br J Clin Pharmacol. 2003. PMID: 12814449 Free PMC article. Clinical Trial.
-
Pharmacokinetics and therapeutic drug monitoring of gentamicin in the elderly.Clin Pharmacokinet. 1999 Oct;37(4):331-41. doi: 10.2165/00003088-199937040-00004. Clin Pharmacokinet. 1999. PMID: 10554048 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical